Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Immunome Inc (IMNM)

197 + Investors. Track Smart Money conviction in IMNM. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +14
Streak
3Q ▲
Buyers last Q
62%

Smart Money Signals — IMNM

Based on 197 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added IMNM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
197 hedge funds hold IMNM right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +39% more funds vs a year ago

fund count last 6Q
+55 new funds entered over the past year (+39% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 62% buying

123 buying77 selling
Last quarter: 123 funds were net buyers (46 opened a brand new position + 77 added to an existing one). Only 77 were sellers (45 trimmed + 32 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~46 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 27 → 27 → 50 → 46. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 34% entered in last year

■ 24% conviction (2yr+) ■ 42% medium ■ 34% new
Only 48 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
🚀

Acceleration phase — new buyers rushing in

41 → 27 → 27 → 50 → 46 new funds/Q
New funds entering each quarter: 27 → 27 → 50 → 46. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊

Mixed cohorts — 28% veterans, 42% new entrants

■ 28% veterans ■ 30% 1-2yr ■ 42% new
Of 203 current holders: 56 (28%) held 2+ years, 61 held 1–2 years, 86 (42%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
🏆

Elite ownership — 49% AUM from top-100 funds

49% from top-100 AUM funds
42 of 197 holders are among the 100 largest funds by AUM, controlling 49% of total institutional value in IMNM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.5
out of 10
Moderate Exit Risk
Exit risk score 4.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IMNM

In 2026 Q1, 123 hedge funds were net buyers of IMNM (46 opened a new position, 77 added to an existing one), while 77 reduced or exited (45 trimmed, 32 sold completely) — a 62% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 49% of total institutional value in IMNM is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +14 funds (more new holders than closures). Total institutional holders: 197.

Hedge Fund Ownership: IMNM

How many hedge funds hold IMNM — quarterly history vs. share price
Quarterly hedge fund ownership of IMNM vs. share price

Market Analysis: IMNM

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IMNM

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Immunome Inc (IMNM) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much IMNM has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
IMNM
-15.3%
XLV
+2.8%

IMNM outperformed XLV by -18.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
IMNM
-11.3%
XLV
+3.9%

Since the filing became public, IMNM outperformed XLV by -15.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

17 top-rated funds 2 high-conviction
Consensus
5.5
/ 10
breadth
×
Elite
2.2
/ 10
conviction
Hedge Fund Positioning: IMNM
197 + Investors

Track Smart Money conviction in IMNM. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 197 183 7.65%
13F Shares 115M 109M 5.57%
Total Value $2.10B $2.28B -7.58%
New Positions 46 50 -4
Increased Positions 75 76 -1
Closed Positions 32 19 +13
Reduced Positions 45 37 +8
Total Calls 3 7 -57.14%
Total Puts 4 6 -33.33%
PUT/CALL Ratio 1.33 0.86 Bearish

Statistics: IMNM

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

197 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IMNM. Verified SEC 13F-HR filings.

QUARTER:
Top 25 IMNM holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Enavate Sciences GP, LLC 22.48% 3,613,799 $79.0M
2 Redmile Group, LLC 8.05% 5,558,885 $121.6M
3 Pivotal bioVenture Partners Investment Advisor LLC 5.73% 732,512 $16.0M
4 Silverarc Capital Management, LLC 4.13% 1,850,278 $40.5M
5 NAN FUNG TRINITY (HK) Ltd 1.72% 714,553 $15.6M
6 Sofinnova Investments, Inc. 1.41% 1,701,904 $37.2M
7 Readystate Asset Management LP 1.28% 1,301,862 $28.5M
8 Parkman Healthcare Partners LLC 0.91% 403,487 $8.8M
9 Atika Capital Management LLC 0.72% 262,900 $5.7M
10 Driehaus Capital Management LLC 0.66% 4,099,901 $89.7M
11 Birchview Capital, LP 0.62% 50,000 $1.1M
12 Sio Capital Management, LLC 0.52% 165,110 $3.6M
13 Atom Investors LP 0.48% 306,880 $6.7M
14 Rock Springs Capital Management LP 0.45% 347,666 $7.6M
15 Tema Etfs LLC 0.41% 275,896 $6.0M
16 Granahan Investment Management, LLC 0.32% 307,021 $6.7M
17 PSP Research LLC 0.31% 20,000 $437K
18 Three Bridge Wealth Advisors, LLC 0.23% 37,615 $823K
19 Burkehill Global Management, LP 0.22% 200,000 $4.4M
20 Informed Momentum Co LLC 0.18% 71,757 $1.6M
21 Jefferies Financial Group Inc. 0.17% 1,160,715 $25.4M
22 Jefferies Financial Group Inc. 0.17% 1,160,700 $25.4M
23 Palumbo Wealth Management LLC 0.17% 32,051 $701K
24 Velan Capital Investment Management LP 0.14% 10,000 $219K
25 Kennedy Capital Management LLC 0.13% 287,030 $6.3M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Immunome Inc (IMNM)

What does the Smart Money Trend signal show for IMNM?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added IMNM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IMNM?

More buyers than sellers — 62% buying: Last quarter: 123 funds were net buyers (46 opened a brand new position + 77 added to an existing one). Only 77 were sellers (45 trimmed + 32 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IMNM holders?

Elite ownership — 49% AUM from top-100 funds: 42 of 197 holders are among the 100 largest funds by AUM, controlling 49% of total institutional value in IMNM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held IMNM?

Mostly new holders — 34% entered in last year: Only 48 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Immunome Inc (IMNM) following the 2026 Q1 hedge fund 13F filings?

As of today, IMNM has moved -11.3% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of -15.2%. Since the quarter end (March 31, 2026), IMNM has gained -15.3% vs +2.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →